STEM -- StemCells, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc.

STEM 14.27

+3.0%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WWS who wrote (194)	1/25/1999 7:18:00 PM
From: scaram(o)uche	Read Replies (1) of 805

Geeeze, you guys are finding good stuff. >> Another caveat lies in whether the grafted cells will cause an immune response in the human host. Though previous rodent work suggests they will not, this question remains unanswered.<< I'll have to see it before I believe it. I still feel that this sort of therapy is likely to be at least more effective if the cells are autologous. So, you want to treat a 70 year old patient for Parkinson's? Can you harvest stem cells from such a patient, or are they exhausted? Is it safe? Would that be a rational target for clinical trials if effective therapy did require patient-specific transplantation? Wonder if these companies (GERN, CTII, etc.) are beginning to talk to BioTransplant regarding the induction of tolerance?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next